The Latin America, Middle East and Africa Dermatome Device Market should witness market growth of 8.4% CAGR during the forecast period (2023-2030).
The market is expanding as a result of technological developments in the industry as well as an increase in pressure ulcers, burn injuries, and skin infections. Players in the market are concentrating on the continuous improvement of technologies to raise the standard of healthcare given to various patients. Technological advancements in dermatome devices have improved their performance and efficiency. Modern dermatomes offer features such as adjustable cutting depth, precision controls, and ergonomic designs, which enhance the accuracy and ease of the grafting procedure.
These innovations draw in specialists in the healthcare industry and help to the expansion of the market. Additionally, the overall increase in healthcare expenditure across the region, including investments in advanced medical devices, positively impacts the market. As healthcare facilities strive to enhance patient outcomes and provide efficient wound care, they invest in high-quality dermatome devices to support better surgical outcomes and patient satisfaction.
Brazil has become a popular location for medical tourism along with a few other emerging nations. Brazil's plastic surgery residency initiatives, some of which are situated inside its public health system, draw foreign doctors, offer plenty of opportunities for beneficial training in aesthetic methods, and foster a conducive environment in the clinic to experiment with cutting-edge treatments. As a result, the nation is attracting a greater number of medical tourists looking for cheaper plastic surgery destinations. Thus, all these elements are projected to accelerate the expansion of the market in the coming years.
The Brazil market dominated the LAMEA Dermatome Device Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $4,189.6 Thousands by 2030. The Argentina market is exhibiting a CAGR of 9% during (2023-2030). Additionally, The UAE market would register a CAGR of 8.2% during (2023-2030).
Based on Application, the market is segmented into Chronic Burn Care Treatments, General Surgery, Plastic Surgery and Reconstructive Surgery & Others. Based on Product, the market is segmented into Powered Dermatome Device (Pneumatic, Battery Operated, and Electric), Knife Dermatome Device and Drum Dermatome Device. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers, Dermatology Clinics and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zimmer Biomet Holdings, Inc., Integra LifeSciences Holdings Corporation, Aesculap, Inc. (B. Braun Melsungen AG), Surtex Instruments Ltd., Richard Wolf GmbH, Shaanxi Xingmao Industry Co., Ltd., Aygun Surgical Instruments Co., Inc. (CEECAT Capital), Humeca BV (Holland Venture), Nouvag AG and Novo Surgical Inc.
The market is expanding as a result of technological developments in the industry as well as an increase in pressure ulcers, burn injuries, and skin infections. Players in the market are concentrating on the continuous improvement of technologies to raise the standard of healthcare given to various patients. Technological advancements in dermatome devices have improved their performance and efficiency. Modern dermatomes offer features such as adjustable cutting depth, precision controls, and ergonomic designs, which enhance the accuracy and ease of the grafting procedure.
These innovations draw in specialists in the healthcare industry and help to the expansion of the market. Additionally, the overall increase in healthcare expenditure across the region, including investments in advanced medical devices, positively impacts the market. As healthcare facilities strive to enhance patient outcomes and provide efficient wound care, they invest in high-quality dermatome devices to support better surgical outcomes and patient satisfaction.
Brazil has become a popular location for medical tourism along with a few other emerging nations. Brazil's plastic surgery residency initiatives, some of which are situated inside its public health system, draw foreign doctors, offer plenty of opportunities for beneficial training in aesthetic methods, and foster a conducive environment in the clinic to experiment with cutting-edge treatments. As a result, the nation is attracting a greater number of medical tourists looking for cheaper plastic surgery destinations. Thus, all these elements are projected to accelerate the expansion of the market in the coming years.
The Brazil market dominated the LAMEA Dermatome Device Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $4,189.6 Thousands by 2030. The Argentina market is exhibiting a CAGR of 9% during (2023-2030). Additionally, The UAE market would register a CAGR of 8.2% during (2023-2030).
Based on Application, the market is segmented into Chronic Burn Care Treatments, General Surgery, Plastic Surgery and Reconstructive Surgery & Others. Based on Product, the market is segmented into Powered Dermatome Device (Pneumatic, Battery Operated, and Electric), Knife Dermatome Device and Drum Dermatome Device. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers, Dermatology Clinics and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zimmer Biomet Holdings, Inc., Integra LifeSciences Holdings Corporation, Aesculap, Inc. (B. Braun Melsungen AG), Surtex Instruments Ltd., Richard Wolf GmbH, Shaanxi Xingmao Industry Co., Ltd., Aygun Surgical Instruments Co., Inc. (CEECAT Capital), Humeca BV (Holland Venture), Nouvag AG and Novo Surgical Inc.
Scope of the Study
By Application
- Chronic Burn Care Treatments
- General Surgery
- Plastic Surgery
- Reconstructive Surgery & Others
By Product
- Powered Dermatome Device
- Pneumatic
- Battery Operated
- Electric
- Knife Dermatome Device
- Drum Dermatome Device
By End-use
- Hospitals
- Ambulatory Surgical Centers
- Dermatology Clinics
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Zimmer Biomet Holdings, Inc.
- Integra LifeSciences Holdings Corporation
- Aesculap, Inc. (B. Braun Melsungen AG)
- Surtex Instruments Ltd.
- Richard Wolf GmbH
- Shaanxi Xingmao Industry Co., Ltd.
- Aygun Surgical Instruments Co., Inc. (CEECAT Capital)
- Humeca BV (Holland Venture)
- Nouvag AG
- Novo Surgical Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. LAMEA Dermatome Device Market by Application
Chapter 4. LAMEA Dermatome Device Market by Product
Chapter 5. LAMEA Dermatome Device Market by End-use
Chapter 6. LAMEA Dermatome Device Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Zimmer Biomet Holdings, Inc.
- Integra LifeSciences Holdings Corporation
- Aesculap, Inc. (B. Braun Melsungen AG)
- Surtex Instruments Ltd.
- Richard Wolf GmbH
- Shaanxi Xingmao Industry Co., Ltd.
- Aygun Surgical Instruments Co., Inc. (CEECAT Capital)
- Humeca BV (Holland Venture)
- Nouvag AG
- Novo Surgical Inc.
Methodology
LOADING...
